The smart way to manage your genomics data analysis
Bluebee’s unique private cloud-based accelerated genomics analysis platform enables fast, efficient and affordable processing of Next Generation Sequencing data. Be it for research, clinical applications, agrigenomics, or beyond, Bluebee’s secure, scalable, and configurable platform supports cross-functional teams with centralized sequence data analysis and storage.
New England Biolabs and Bluebee Partner to Deliver an End-To-End Data Analysis Solution for NEBNext Direct Target Enrichment
Bluebee and New England Biolabs, Inc. (NEB®) have partnered to provide a secure and convenient data processing solution for NEB’s NEBNext Direct target enrichment technology.
Bluebee adds NEN 7510:2011 Certification to its Security Portfolio
The security of Bluebee’s customer data is a priority highlighted by the recent NEN 7510:2011 certification, and demonstrates the company’s continued strive for security compliance and excellence in handling healthcare data.
PacBio and Bluebee Launch De Novo Genome Assembly Pipeline on the Bluebee Analysis Platform
October 9th, 2017 — Bluebee, a company driving genomic data-driven medicine, and Pacific Biosciences of California, Inc. (NASDAQ:PACB), the leader in long-read sequencing, announced they have integrated the PacBio® de novo assembly pipeline onto the Bluebee® genomics analysis platform.
Vlad-Mihai Sima, Head of Research
“Data handling is now the bottleneck, it costs more to analyze a genome than to sequence a genome. Our focus is driving the analysis cost down.”